RA
AGN

Rovida Advisors’s Allergan plc AGN Stock Holding History

Rovida Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-136,967
Closed -$26.2M – 60
2019
Q4 		$26.2M Hold
136,967
– – 1.39% 27
2019
Q3 		$23.1M Sell
136,967
-15,933
-10% -$2.6M 1.36% 28
2019
Q2 		$25.6M Hold
152,900
– – 1.51% 26
2019
Q1 		$22.4M Hold
152,900
– – 1.52% 24
2018
Q4 		$20.4M Hold
152,900
– – 1.69% 23
2018
Q3 		$29.1M Hold
152,900
– – 2.13% 18
2018
Q2 		$25.5M Hold
152,900
– – 2.09% 17
2018
Q1 		$25.7M Hold
152,900
– – 2.41% 17
2017
Q4 		$25M Hold
152,900
– – 2.62% 17
2017
Q3 		$31.3M Hold
152,900
– – 3.31% 15
2017
Q2 		$37.2M Buy
+152,900
New +$35.9M 5.12% 10

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rovida Advisors's AGN Position: Q1 2020 in Review

Rovida Advisors sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 136,967 shares — an estimated $26.2M sold.

Rovida Advisors first reported a position in AGN in Q2 2017 and held it in 11 quarters. The position peaked at $37.2M in Q2 2017. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Rovida Advisors reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Rovida Advisors sold 136,967 Allergan plc shares in Q1 2020, an estimated $26.2M.
  • Rovida Advisors first reported a position in Allergan plc in Q2 2017 and held it in 11 quarters.
  • Rovida Advisors's Allergan plc position peaked at $37.2M in Q2 2017.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Rovida Advisors's 13F filing for Q1 2020, filed 13 May 2020.